CRISA is conducting clinical trials to the advancement of medical science
# | Trial Name | Therapeutic Area | Contact Person |
---|---|---|---|
1 | A 40-week study comparing the efficacy and safety of once weekly IcoSema and daily insulin glargine 100 units/mL in participants with type 2 diabetes inadequately controlled on oral anti-diabetic drugs. COMBINE 4 Start date: 02 April 2024 | Endocrinology | Nonkqubela Bantubani nbantubani@crisa.org.za |
2 | A randomised, double-blind, placebo-controlled Multicenter Study to Evaluate the Effect of Inclisiran on Preventing Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke (victorion-i-prevent). Start date: 06 November 2023 End date: Ongoing | Cardiovascular | Nonkqubela Bantubani nbantubani@crisa.org.za |
3 | A randomised, Double-Blind, Parallel Design, Repeat Dose, 2-arm, Multicenter Study Comparing the Efficacy, Safety, Immunogenicity, and Pharmacokinetic Profiles of AVT03 and US-Prolia® in Postmenopausal Women with Osteoporosis. Start date: 06 October 2022 End date: Ongoing | Orthopedics | Nonkqubela Bantubani nbantubani@crisa.org.za |
4 | A randomised, double-blind, placebo-controlled, Phase 1/2 study to evaluate inhaled IBIO123 in participants with mild to moderate COVID-19 illness. Start date: 05 September 2022 End date: 8 December 2022 | Infectious Diseases | Nonkqubela Bantubani nbantubani@crisa.org.za |